BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 7046377)

  • 1. Fate of epoxides.
    Oesch F
    Adv Exp Med Biol; 1981; 136 Pt A():39-52. PubMed ID: 7046377
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymes.
    Nordqvist M; Thakker DR; Vyas KP; Yagi H; Levin W; Ryan DE; Thomas PE; Conney AH; Jerina DM
    Mol Pharmacol; 1981 Jan; 19(1):168-78. PubMed ID: 7207460
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on metabolism and toxicity of styrene: III. The effect of metabolic inactivation by rat-liver S9 on the mutagenicity of phenyloxirane toward Salmonella typhimurium.
    Yoshikawa K; Isobe M; Watabe I; Takabatake E
    Mutat Res; 1980 Jul; 78(3):219-26. PubMed ID: 7001214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hepatic microsomal and cytosolic subcellular fractions on the mutagenic activity of epoxide-containing compounds in the Salmonella assay.
    El-Tantawy MA; Hammock BD
    Mutat Res; 1980 Sep; 79(1):59-71. PubMed ID: 7001221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity and tumorigenicity of phenanthrene and chrysene epoxides and diol epoxides.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Mah HD; Karle JM; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1979 Oct; 39(10):4069-77. PubMed ID: 383279
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of genotoxic agents: control of reactive epoxides by hydrolase and transferase reactions.
    Oesch F
    IARC Sci Publ; 1984; (59):73-83. PubMed ID: 6400098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of ultimate mutagenic species by diverse enzymes.
    Oesch F; Doehmer J; Friedberg T; Glatt H; Oesch-Bartlomowicz B; Platt KL; Steinberg P; Utesch D; Thomas H
    Prog Clin Biol Res; 1990; 340B():49-65. PubMed ID: 2168050
    [No Abstract]   [Full Text] [Related]  

  • 8. Highly tumorigenic bay-region diol epoxides from the weak carcinogen benzo[c]phenanthrene.
    Jerina DM; Sayer JM; Yagi H; Croisy-Delcey M; Ittah Y; Thakker DR; Wood AW; Chang RL; Levin W; Conney AH
    Adv Exp Med Biol; 1981; 136 Pt A():501-23. PubMed ID: 7046379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biotransformation of 1-hexadecene to carcinogenic 1,2-epoxyhexadecane by hepatic microsomes.
    Watabe T; Yamada N
    Biochem Pharmacol; 1975 May; 24(9):1051-3. PubMed ID: 1156447
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism of benzo[a]pyrene. VI. Stereoselective metabolism of benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol to diol epoxides.
    Thakker DR; Yagi H; Akagi H; Koreeda M; Lu AH; Levin W; Wood AW; Conney AH; Jerina DM
    Chem Biol Interact; 1977 Mar; 16(3):281-300. PubMed ID: 862130
    [No Abstract]   [Full Text] [Related]  

  • 11. Bacterial mutagenicity investigation of epoxides: drugs, drug metabolites, steroids and pesticides.
    Glatt H; Jung R; Oesch F
    Mutat Res; 1983 Oct; 111(2):99-118. PubMed ID: 6355833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent intercalative binding to DNA in relation to the mutagenicity of hydrocarbon epoxides and N-acetoxy-2-acetylaminofluorene.
    Drinkwater NR; Miller JA; Miller EC; Yang NC
    Cancer Res; 1978 Oct; 38(10):3247-55. PubMed ID: 356963
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement of epoxide-metabolizing enzyme activities by pure PCB isomers.
    Ahotupa M
    Biochem Pharmacol; 1981 Jul; 30(13):1866-9. PubMed ID: 6791659
    [No Abstract]   [Full Text] [Related]  

  • 14. Increase of 2,3-epoxybutane mutagenicity by glutathione-S-transferases.
    de Meester C
    Toxicol Lett; 1984 Jun; 21(3):255-62. PubMed ID: 6377584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alphatic 3,4-epoxyalcohols. Metabolism by epoxide hydrase and mutagenic activity.
    Ortiz de Montellano PR; Boparai AS
    Biochim Biophys Acta; 1978 Dec; 544(3):504-13. PubMed ID: 728469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of a vicinal, non-bay-region dihydrodiol-epoxide in the activation of dibenzo[a,e]fluoranthene into bacterial mutagens.
    Malaveille C; Hautefeuille A; Perin-Roussel O; Saguem S; Croisy-Delcey M; Zajdela F; Bartsch H
    Carcinogenesis; 1984 Oct; 5(10):1263-6. PubMed ID: 6386214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The perinatal development of epoxide-metabolizing enzyme activities in liver and extrahepatic organs of guinea pig and rabbit.
    James MO; Foureman GL; Law FC; Bend JR
    Drug Metab Dispos; 1977; 5(1):19-28. PubMed ID: 13972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of epoxide metabolism by epoxide hydrolase and glutathione S-transferase associated with age and genotype in Drosophila melanogaster.
    Ottea JA; Harshman LG; Hammock B
    Mutat Res; 1987 Apr; 177(2):247-54. PubMed ID: 3104776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chlorinated paraffins on some drug-metabolizing enzymes in rat liver and in the Ames test.
    Meijer J; Rundgren M; Aström A; DePierre JW; Sundvall A; Rannug U
    Adv Exp Med Biol; 1981; 136 Pt A():821-8. PubMed ID: 7046383
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity of liver microsomal mono-oxygenases on some epoxide-forming cyclic tricyclic drugs. I. Kinetics in vitro.
    Pachecka J; Salmona M; Cantoni L; Mussini E; Pantarotto C; Frigerio A; Belvedere G
    Xenobiotica; 1976 Oct; 6(10):593-8. PubMed ID: 983116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.